Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Catalyst Pharmaceuticals (CPRX) Shares Repurchased (2016 - 2022)

Historic Shares Repurchased for Catalyst Pharmaceuticals (CPRX) over the last 5 years, with Q2 2022 value amounting to $4.4 million.

  • Catalyst Pharmaceuticals' Shares Repurchased rose 1891.89% to $4.4 million in Q2 2022 from the same period last year, while for Mar 2023 it was $4.4 million, marking a year-over-year decrease of 6962.58%. This contributed to the annual value of $6.9 million for FY2022, which is 4291.74% down from last year.
  • Catalyst Pharmaceuticals' Shares Repurchased amounted to $4.4 million in Q2 2022, which was up 1891.89% from $2.6 million recorded in Q1 2022.
  • Catalyst Pharmaceuticals' 5-year Shares Repurchased high stood at $5.1 million for Q3 2021, and its period low was $300000.0 during Q1 2021.